aspirin has been researched along with 3-(5-chlorofuran-2-yl)-5-methyl-4-phenylisoxazole in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bruno, A; Dovizio, M; Lavecchia, A; Malerba, P; Marcantoni, E; Patrignani, P; Perrone, MG; Scilimati, A; Simone, L; Tacconelli, S; Vitale, P | 1 |
1 other study(ies) available for aspirin and 3-(5-chlorofuran-2-yl)-5-methyl-4-phenylisoxazole
Article | Year |
---|---|
Synthesis, pharmacological characterization, and docking analysis of a novel family of diarylisoxazoles as highly selective cyclooxygenase-1 (COX-1) inhibitors.
Topics: Animals; Blood Platelets; Cell Line; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Epoprostenol; Female; Fibrinolytic Agents; Furans; Humans; Isoxazoles; Mice; Mice, Inbred C57BL; Molecular Docking Simulation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet-Rich Plasma; Structure-Activity Relationship; Thromboxane A2 | 2013 |